# E121: Obinutuzumab in SLE-LN

Page: https://stenobird.com/podcast/the-evidence-based-rheumatology-podcast-1130175/e121-obinutuzumab-in-sle-ln
Text version: https://stenobird.com/podcast/the-evidence-based-rheumatology-podcast-1130175/e121-obinutuzumab-in-sle-ln.md
Podcast: [The Evidence Based Rheumatology Podcast](https://stenobird.com/podcast/the-evidence-based-rheumatology-podcast-1130175)
Published: 2025-04-02T17:07:44+00:00
Episode link: https://msputman.podbean.com/e/e121-obinutuzumab-in-sle-ln/
Audio file: https://mcdn.podbean.com/mf/web/9vj6q6hjumcaagy6/E121.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/the-evidence-based-rheumatology-podcast-1130175/episodes/e121-obinutuzumab-in-sle-ln
Duration seconds: 1094

## Resource

Another day, another b cell podcast. Seems to be all the rage! This week I discuss the recently published NEJM trial of the anti CD20 agent obinutuzumab in lupus nephritis. Worth a read and listen, paper can be found here: https://www.nejm.org/doi/full/10.1056/NEJMoa2410965

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/the-evidence-based-rheumatology-podcast-1130175/episodes/e121-obinutuzumab-in-sle-ln/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/the-evidence-based-rheumatology-podcast-1130175/e121-obinutuzumab-in-sle-ln.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.